...
首页> 外文期刊>Chemicke Zvesti >Improved protocol for synthesis of N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy) quinazolin-4-amine (gefitinib)
【24h】

Improved protocol for synthesis of N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy) quinazolin-4-amine (gefitinib)

机译:改进的合成方案(3-氯-4-氟苯基)-7-甲氧基-6-(3-甲甲蛋白-4-基丙氧基)喹唑啉-4-胺(Gefitinib)

获取原文
获取原文并翻译 | 示例
           

摘要

An improved three-step process for the synthesis of gefitinib from readily available starting material is discussed in this protocol. The protocol is based on the synthesis, isolation, characterization of novel intermediates and their application in the alkylation step for the synthesis of gefitinib. Excellent results were achieved over the conventional synthetic methodologies. Isolation of these intermediates were effective in replacing high boiling solvent with low boiling solvent(s) but also in eliminating base from the reaction. These conditions led to effective elimination of all the prior art reported impurities. This high-yielding process is cost-effective with isolable and stable intermediates. These intermediates were characterized using NMR, mass spectroscopy, DSC and XRPD analyses.
机译:在该方案中讨论了从容易获得的原料合成吉非替尼的改进的三步方法。 该方案基于新型中间体的合成,分离,表征及其在合成吉替尼的烷基化步骤中的应用。 通过传统的合成方法实现了优异的结果。 这些中间体的分离有效地用低沸点溶剂更换高沸点溶剂,但也可以消除反应的基础。 这些条件导致了消除所有现有技术报告的杂质。 这种高产过程具有可分离和稳定的中间体具有成本效益。 使用NMR,质谱,DSC和XRPD分析表征这些中间体。

著录项

  • 来源
    《Chemicke Zvesti》 |2019年第1期|共8页
  • 作者单位

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

    Oncogen Pharma Sdn Bhd No.3 Jalan Jururancang U1/21 Hicom Glenmarie Industrial Park 40150 Shah Alam Selangor Malaysia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

    Gefitinib; Iressa; Alkali metal salts; O-Alkylation; Novel intermediate; Improved protocol;

    机译:Gefitinib;Iressa;碱金属盐;O-烷基化;新的中间;改进的协议;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号